Sonoma Pharmaceuticals Q1 EPS $(0.07) Misses $(0.06) Estimate, Sales $3.39M Miss $3.94M Estimate
Sonoma Pharmaceuticals Q1 EPS $(0.07) Misses $(0.06) Estimate, Sales $3.39M Miss $3.94M Estimate
Sonoma Pharmaceuticals第一季度每股收益爲$(0.07)，低於$(0.06)的預期，銷售額爲339萬美元，低於394萬美元的預期。
Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.06) by 16.67 percent. This is a 75.86 percent increase over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $3.39 million which missed the analyst consensus estimate of $3.94 million by 13.93 percent. This is a 1.05 percent decrease over sales of $3.43 million the same period last year.
Sonoma Pharmaceuticals（納斯達克SNOA）報告季度每股虧損0.07美元，未達到分析師預期的0.06美元，下降了16.67%。與去年同期每股虧損0.29美元相比，這是一個增長了75.86%的數字。該公司報告季度銷售額339萬美元，未達到分析師預期的394萬美元，下降了13.93%。與去年同期的銷售額343萬美元相比，這是一個1.05%的降幅。
資訊熱榜
更新時間